Jean-Ehrland RICCI
jer-06.bsky.social
Research Director at Inserm, Nice & Editor-in-Chief of Oncogenesis. Our team, composed of researchers and clinicians, studies how tumor metabolism shapes anti-tumor immunity and contributes to cancer cell adaptation and therapy resistance
👤 Joined on 04 December 2024
471
Followers
586
Following
45
Total Posts
📜 Kullanıcı Geçmişi
- 04 Ara 2024, 16:36
🎉 Bluesky'e katıldı - İlk kullanıcı adı:
@jer-06.bsky.social
🚫 Blokladığı Kullanıcılar
❤️ Beğendiği Gönderiler
This week #JournalClub @labsoap.bsky.social #extracellularvesicles #TNBC #cancerstemcells www.cell.com/cancer-cell/...
Show Post
Antibiotics designed by AI, and other key developments in the ongoing battle against antimicrobial resistance go.nature.com/4twQntn
Show Post
More than thrilled to share that I’ve been promoted to full (tenured) Professor @harvardmed.bsky.social @harvard.edu! This only happened because of the hard work of many people, but I want to dedicate this promotion to my grandmas, Nonna Maria & Nonna Vevè. A #FirstGen thread 🧵 1/x
Show Post
RESEARCH | @crismunozp.bsky.social @idibell.bsky.social Glucose deprivation triggers secretion of cytokine LIF, which promotes angiogenesis and immune suppression in lung cancer models 🧪
Show Post
HUGE congratulations to our very own Julia Brunner for her paper describing cell-state dependent engagement of the malate-aspartate shuttle, out today!! Many thanks to all lab members, funders, and colleagues who supported the work, and stay tuned for more from Julia very soon!
Show Post